(Q71171008)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8674284%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

title

Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8674284%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference

1 reference

neoplastic invasiveness

1 reference

C Holst-Hansen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8674284%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

B Johannessen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8674284%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

G Høyer-Hansen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8674284%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

J Rømer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8674284%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

V Ellis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8674284%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

N Brünner

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8674284%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

publication date

1 May 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8674284%20AND%20SRC:MED&resulttype=core&format=json

Clinical & Experimental Metastasis

16 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8674284%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8674284%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8674284%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

page(s)

297-307

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8674284%20AND%20SRC:MED&resulttype=core&format=json

Antibodies to plasminogen activator inhibit human tumor metastasis

16 October 2019

cites work

1 reference

12 December 2020

Prevention of metastasis by inhibition of the urokinase receptor

1 reference

12 December 2020

lacZ transduced human breast cancer xenografts as an in vivo model for the study of invasion and metastasis

1 reference

12 December 2020

Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1.

1 reference

12 December 2020

Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer

1 reference

12 December 2020

Effects of linoleic acid on the growth and metastasis of two human breast cancer cell lines in nude mice and the invasive capacity of these cell lines in vitro.

1 reference

12 December 2020

Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor

1 reference

12 December 2020

Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme

1 reference

12 December 2020

Enzyme-linked immunosorbent assay for human urokinase-type plasminogen activator and its proenzyme using a combination of monoclonal and polyclonal antibodies

1 reference

12 December 2020

A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer.

1 reference

12 December 2020

Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines

1 reference

12 December 2020

Enzyme-linked immunosorbent assay of urokinase-type plasminogen activator (uPA) in cytosolic extracts of human breast cancer tissue

1 reference

12 December 2020

A new in vitro assay for quantitating tumor cell invasion

1 reference

12 December 2020

Cellular receptor for urokinase-type plasminogen activator: function in cell-surface proteolysis

1 reference

12 December 2020

Expression of uPA and its receptor by both neoplastic and stromal cells during xenograft invasion

1 reference

12 December 2020

Modulation of plasminogen activator systems by matrix components in two breast cancer cell lines: MCF-7 and MDA-MB-231.

1 reference

12 December 2020

Inhibition of urokinase-type plasminogen activator by antibodies: the effect on dissemination of a human tumor in the nude mouse

1 reference

12 December 2020

Complementation between urokinase-producing and receptor-producing cells in extracellular matrix degradation

1 reference

12 December 2020

Improved medium for extraction of plasminogen activator from tissue

1 reference

12 December 2020

Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells

1 reference

12 December 2020

Cell-induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the NH2-terminal domain of the urokinase receptor

1 reference

12 December 2020

Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization

1 reference

12 December 2020

Urokinase receptor and colorectal cancer survival.

1 reference

12 December 2020

Tumor Cell Invasion Inhibited by TIMP-2

1 reference

12 December 2020

A soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria

1 reference

12 December 2020

Quantitation of the receptor for urokinase plasminogen activator by enzyme-linked immunosorbent assay

1 reference

12 December 2020

The plasminogen activation system in human colon cancer: messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumor stroma

1 reference

12 December 2020

Plasminogen activator inhibitors: hormonally regulated serpins

1 reference

12 December 2020

In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bound urokinase

1 reference

12 December 2020

Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor

1 reference

12 December 2020

The interaction of plasminogen activator inhibitor 1 with plasminogen activators (tissue-type and urokinase-type) and fibrin: localization of interaction sites and physiologic relevance

1 reference

12 December 2020

Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture

1 reference

12 December 2020

Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes

1 reference

12 December 2020

Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin

1 reference

12 December 2020

Plasminogen activator inhibitor type 1 in cancer: therapeutic and prognostic implications.

1 reference

12 December 2020

In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion

1 reference

12 December 2020

Inhibition of metastasis of Lewis lung carcinoma by a synthetic peptide within growth factor-like domain of urokinase in the experimental and spontaneous metastasis model

1 reference

12 December 2020

Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis

1 reference

12 December 2020

The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes

1 reference

12 December 2020

Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy

1 reference

12 December 2020

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

12 December 2020

A phase I study of intravenous bryostatin 1 in patients with advanced cancer

1 reference

12 December 2020

Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells--inhibitor neutralization and one-step affinity purification

1 reference

12 December 2020

Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes

1 reference

12 December 2020

Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors

1 reference

12 December 2020

Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer.

1 reference

12 December 2020

A cleaved form of the receptor for urokinase-type plasminogen activator in invasive transplanted human and murine tumors

1 reference

12 December 2020

The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy

1 reference

12 December 2020

Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain

1 reference

12 December 2020

Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells

1 reference

12 December 2020

Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer

1 reference

12 December 2020

Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue

1 reference

12 December 2020

Urokinase receptor in breast cancer tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodies

1 reference

12 December 2020

Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer

1 reference

12 December 2020

The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants

1 reference

12 December 2020

Plasminogen activators, tissue degradation, and cancer

1 reference

12 December 2020

Glucocorticoid modulation of plasminogen activators and of one of their inhibitors in the human mammary carcinoma cell line MDA-MB-231.

1 reference

12 December 2020

Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer

1 reference

12 December 2020

Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma

1 reference

12 December 2020

Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production.

1 reference

12 December 2020

Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases

1 reference

12 December 2020

Involvement of the plasmin system in dissociation of the insulin-like growth factor-binding protein complex

1 reference

12 December 2020

High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis

1 reference

12 December 2020

Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity

1 reference

12 December 2020

Identifiers

1 reference